An implementation trial of continuous quality improvement for antenatal syphilis and HIV detection and treatment in Indonesia: The MENJAGA study
印度尼西亚产前梅毒和艾滋病毒检测和治疗持续质量改进的实施试验:MENJAGA 研究
基本信息
- 批准号:MR/T038837/1
- 负责人:
- 金额:$ 121.67万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The dual elimination of mother-to-child transmission (EMTCT) of HIV and syphilis through screening and treatment of pregnant women has been identified as a global public health priority. Indonesia has set an ambitious EMTCT target of 2030. Currently, only 27% of pregnant women are tested for HIV and 1% for syphilis (using a mixture of rapid tests and laboratory-based testing), this is despite 98% of pregnant women attending antenatal care at least once during pregnancy. Moreover, only 48% of those testing positive for HIV and 30% for syphilis receive treatment. This poses a formidable challenge and is recognised as one of the most significant gaps in antenatal care in Indonesia. Persistent barriers to antenatal screening for HIV/syphilis include (but are not restricted to): limited awareness among health workers of the need for universal screening; some women are fearful of the test; lack of local standard operating procedures at the clinic level; supply chain gaps in tests and treatments; problems with the referral processes; and difficulties tracking women as they move across the health system. Context-specific interventions to better support the integration of HIV and syphilis testing and treatment into the Antenatal care (ANC) platform are urgently needed in Indonesia. Continuous Quality Improvement (CQI), which involves local ANC teams systematically collecting and reflecting on local data to inform the design and implementation of service delivery, has been effectively used to strengthen ANC services in a number of Sub-Saharan African countries. This approach holds considerable promise for Indonesia, a highly populous and diverse country where a 'one size fits all' approach to the delivery of quality ANC rarely applies. Using a cluster-randomised design, we will evaluate the effectiveness, cost-effectiveness, acceptability, fidelity and reach of a multi-faceted CQI intervention to improve antenatal testing and treatment of HIV and syphilis in public and private ANC clinics in 6 districts across 3 Provinces (West Java, South Sumatra and South Kalimantan). This 3-year multi-disciplinary study will involve clinicians, epidemiologists, economists, social scientists, health services researchers and policy-makers from the Indonesian Ministry of Health (research partner), the London School of Hygiene & Tropical Medicine, the Universitas of Gadjah Mada, the University of Sebelas Maret and the Kirby Institute. A range of other stakeholders will be involved throughout the study (e.g. patient advocacy groups; implementing agencies; specialist professional associations; clinics and ANC services) to assess the appropriateness and acceptability of the intervention and barriers and facilitators to scale up. This research has the potential to contribute significantly to improved maternal and child health in Indonesia while also strengthening the underlying health system.
通过对孕妇进行筛查和治疗来消除艾滋病毒和梅毒的母婴双重传播已被确定为全球公共卫生优先事项。印度尼西亚制定了雄心勃勃的2030年消除母婴传播目标。目前,只有27%的孕妇接受艾滋病毒检测,1%接受梅毒检测(使用快速检测和实验室检测的混合方法),尽管98%的孕妇在怀孕期间至少接受一次产前护理。此外,在艾滋病毒检测呈阳性的人中,只有48%和30%的梅毒检测呈阳性的人接受治疗。这是一项艰巨的挑战,被认为是印度尼西亚产前保健方面最重大的差距之一。产前艾滋病毒/梅毒筛查的持续障碍包括(但不限于):卫生工作者对普及筛查必要性的认识有限;一些妇女害怕检测;诊所一级缺乏当地标准作业程序;检测和治疗的供应链缺口;转诊程序存在问题;在妇女在卫生系统中流动时难以跟踪她们。印度尼西亚迫切需要采取针对具体情况的干预措施,以更好地支持将艾滋病毒和梅毒检测和治疗纳入产前护理平台。持续质量改进(CQI)涉及当地的产前护理团队系统地收集和思考当地数据,为服务提供的设计和实施提供信息,已被有效地用于加强撒哈拉以南非洲一些国家的产前护理服务。这种方法为印度尼西亚带来了相当大的希望,印度尼西亚是一个人口众多、多样化的国家,在提供优质ANC方面很少采用“一刀切”的方法。我们将采用分组随机设计,评估多方面CQI干预的有效性、成本效益、可接受性、保真度和覆盖范围,以改善3个省(西爪哇、南苏门答腊和南加里曼丹)6个地区的公立和私立ANC诊所的产前检测和艾滋病毒和梅毒治疗。这项为期3年的多学科研究将涉及来自印度尼西亚卫生部(研究合作伙伴)、伦敦卫生与热带医学学院、Gadjah Mada大学、Sebelas Maret大学和Kirby研究所的临床医生、流行病学家、经济学家、社会科学家、卫生服务研究人员和政策制定者。一系列其他利益相关者将参与整个研究(例如患者倡导团体;执行机构;专家专业协会;诊所和ANC服务),以评估干预措施的适当性和可接受性以及扩大规模的障碍和促进者。这项研究有可能大大有助于改善印度尼西亚的孕产妇和儿童健康,同时也加强了基本的卫生系统。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Supply-side readiness to deliver HIV testing and treatment services in Indonesia: Going the last mile to eliminate mother-to-child transmission of HIV.
- DOI:10.1371/journal.pgph.0000845
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Economic evaluation of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low- and middle-income countries: A systematic review.
- DOI:10.1371/journal.pone.0253135
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Saweri OPM;Batura N;Al Adawiyah R;Causer LM;Pomat WS;Vallely AJ;Wiseman V
- 通讯作者:Wiseman V
Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: a systematic review.
- DOI:10.1136/bmjgh-2022-009408
- 发表时间:2022-11
- 期刊:
- 影响因子:8.1
- 作者:Zhang, Ye;Guy, Rebecca;Camara, Hawa;Applegate, Tanya L.;Wiseman, Virginia;Treloar, Carla;Lafferty, Lise
- 通讯作者:Lafferty, Lise
The costs of scaling up HIV and syphilis testing in low- and middle-income countries: a systematic review.
- DOI:10.1093/heapol/czab030
- 发表时间:2021-06-25
- 期刊:
- 影响因子:3.2
- 作者:Adawiyah RA;Saweri OPM;Boettiger DC;Applegate TL;Probandari A;Guy R;Guinness L;Wiseman V
- 通讯作者:Wiseman V
Challenges to integrating programs for the elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B into antenatal care: Experiences from Indonesia.
将消除艾滋病毒、梅毒和乙型肝炎母婴传播计划纳入产前保健的挑战:印度尼西亚的经验。
- DOI:10.1371/journal.pgph.0002977
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Wulandari LPL
- 通讯作者:Wulandari LPL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Virginia Wiseman其他文献
Economics of Health Care Financing: The Visible Hand
医疗保健融资经济学:看得见的手
- DOI:
10.1007/978-0-230-21573-3 - 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
C. Donaldson;K. Gerard;Stephen Jan;C. Mitton;Virginia Wiseman - 通讯作者:
Virginia Wiseman
Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection
- DOI:
10.1186/s12955-024-02234-1 - 发表时间:
2024-02-13 - 期刊:
- 影响因子:3.400
- 作者:
Patrick Miao;Fern Terris-Prestholt;Christopher K. Fairley;Joseph D. Tucker;Virginia Wiseman;Philippe Mayaud;Ying Zhang;Jane Rowley;Sami Gottlieb;Eline L. Korenromp;Caroline G. Watts;Jason J. Ong - 通讯作者:
Jason J. Ong
Economics of Health Care Financing: the Visible Hand. (2nd Edition)
医疗保健融资经济学:看得见的手。
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
Cam Donaldson;Karen Gerard;C. Mitton;Stephen Jan;Virginia Wiseman - 通讯作者:
Virginia Wiseman
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual
- DOI:
10.1016/j.jval.2023.05.015 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
Aris Angelis;Martin Harker;John Cairns;Mikyung Kelly Seo;Rosa Legood;Alec Miners;Virginia Wiseman;Kalipso Chalkidou;Richard Grieve;Andrew Briggs - 通讯作者:
Andrew Briggs
Resource Allocation within Australian Indigenous Communities: A Program for Implementing Vertical Equity
- DOI:
10.1023/a:1009458714162 - 发表时间:
2000-09-01 - 期刊:
- 影响因子:1.600
- 作者:
Virginia Wiseman;Stephen Jan - 通讯作者:
Stephen Jan
Virginia Wiseman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Virginia Wiseman', 18)}}的其他基金
Expanding syphilis screening among pregnant women in Indonesia using the rapid dual test for syphilis & HIV with capacity building: The DUALIS Study
使用梅毒快速双重检测扩大印度尼西亚孕妇梅毒筛查
- 批准号:
MR/Y004825/1 - 财政年份:2024
- 资助金额:
$ 121.67万 - 项目类别:
Research Grant
The DOMINO Study: Measuring and mitigating the indirect effects of COVID-19 on TB and HIV care in Indonesia
DOMINO 研究:衡量和减轻 COVID-19 对印度尼西亚结核病和艾滋病毒护理的间接影响
- 批准号:
MR/V030825/1 - 财政年份:2020
- 资助金额:
$ 121.67万 - 项目类别:
Research Grant
Making health financing work for the poor: An evaluation of equity in health systems financing in Indonesia
让卫生筹资为穷人服务:对印度尼西亚卫生系统筹资公平性的评估
- 批准号:
MR/P013996/1 - 财政年份:2017
- 资助金额:
$ 121.67万 - 项目类别:
Research Grant
相似国自然基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
- 批准号:81973152
- 批准年份:2019
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
Application of the Telemedicine for Reach, Education, Access, and Treatment delivery model to engage emerging adults in Diabetes Self-Management Education and Support (TREAT-ED)
应用远程医疗覆盖、教育、获取和治疗提供模式,让新兴成年人参与糖尿病自我管理教育和支持 (TREAT-ED)
- 批准号:
10651947 - 财政年份:2023
- 资助金额:
$ 121.67万 - 项目类别:
Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM)
团队支持在不同人群中使用 CGM 改善血糖控制 (TEAM CGM)
- 批准号:
10659721 - 财政年份:2023
- 资助金额:
$ 121.67万 - 项目类别:
Optimizing Use of Advanced Diabetes Technology for Self-Management in Adolescents with Type 1 Diabetes: Integration of Real-Time Glucose and Narrative Data
优化使用先进糖尿病技术对 1 型糖尿病青少年进行自我管理:实时血糖和叙述数据的集成
- 批准号:
10569293 - 财政年份:2023
- 资助金额:
$ 121.67万 - 项目类别:
Implementation of a diabetes navIgator to Mitigate disPArities and improve CGM upTake and sustained use across the lifespan of T1D (IMPACT T1D)
实施糖尿病导航仪以减少差异并提高 CGM 的采用率以及在 T1D 整个生命周期中的持续使用 (IMPACT T1D)
- 批准号:
10708086 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
The Effect of Interval Exercise on Functional Outcomes in Veterans with COPD and OSA
间歇运动对患有慢性阻塞性肺病和阻塞性睡眠呼吸暂停的退伍军人功能结果的影响
- 批准号:
10597107 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
Support to Adopt and Retain Technology (StART) CGM: A pilot study to support continuous glucose monitoring in primary care
支持采用和保留技术 (StART) CGM:一项支持初级保健中连续血糖监测的试点研究
- 批准号:
10700157 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:
10511276 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
T1DTechCHW: Enhancing the Community Health Worker (CHW) Model to Promote Diabetes Technology Use in Young Adults from Underrepresented Minority Groups (YA-URMs) with Type 1 Diabetes (T1D)
T1DTechCHW:加强社区卫生工作者 (CHW) 模式,促进患有 1 型糖尿病 (T1D) 的弱势少数群体 (YA-URM) 年轻人使用糖尿病技术
- 批准号:
10596642 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:
10709518 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:
Support to Adopt and Retain Technology (StART) CGM: A pilot study to support continuous glucose monitoring in primary care
支持采用和保留技术 (StART) CGM:一项支持初级保健中连续血糖监测的试点研究
- 批准号:
10523548 - 财政年份:2022
- 资助金额:
$ 121.67万 - 项目类别:














{{item.name}}会员




